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Abstract
Numerous investigations demonstrate that the problem of corruption in the health sector is enormous and 
has grave negative consequences for patients. Nevertheless, the problem of corruption in health systems is far 
from eminent in the international health policy debate. Hutchinson, Balabanova, and McKee have identifed in 
their Editorial five reasons why the health policy community has been reluctant to talk about it: (1) Problem of 
defining corruption; (2) Some corrupt practices are actually ways of making dysfunctional systems work; (3) 
The serious challenges to researching corruption; (4) Concerns that focus on corruption is a form of victim 
blaming that ignores larger issues; and (5) Lack of evidence about what works to tackle it. In this commentary, 
we pay a closer and critical look at these five excuses for doing nothing. We conclude that the vast majority of the 
world population, being the poor in low and middle-income countries (LMICs) who disproportionately suffer 
from the problem of corruption in health systems, need good people with high moral and ethical principles who 
have the courage to disregard these five reasons. The poor need good people who understand that it is crucial 
to first acknowledge this problem, despite the obvious uncertainties involved, before you can change it. The 
poor therefore need good editors, good policy-makers, good managers, and good clinicians. We agree with the 
authors that we first need to talk about corruption. But above all, we need good people who are subsequently 
willing to walk the talk.
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The editorial by Hutchinson et al1 starts with pointing out that some issues, which are wrong by any moral or ethical framework, are seldom discussed in public. 
This silence leads to a passive acceptance that nothing can 
be done to stop it. The authors subsequently state that the 
medical scientific and health policy community have their 
own dirty secret. It is corruption in health systems. The 
authors notice that our failure to confront this problem is all 
the more astonishing given that numerous investigations, for 
instance research performed by Transparency International, 
repeatedly confirm that the health sector is among the most 
corrupt in many nations worldwide. Corruption in health 
systems subverts the trust that supports efficient and fair 
medical care. And corruption costs lives. In the editorial 
the researchers reflect on the five reasons why it apparently 
is so difficult for the health policy community to initiate 
a debate on corruption in health systems: (1) Problem of 
defining corruption; (2) Some corrupt practices are actually 
ways of making dysfunctional systems work; (3) The serious 
challenges to researching corruption; (4) Concerns that focus 
on corruption is a form of victim blaming that ignores larger 
issues; and (5) Lack of evidence about what works to tackle it.1
In this commentary, we would like to start with emphasizing 
that a problem that is not acknowledged, cannot be changed. 
In order to address corruption in health systems, you first 
need to acknowledge its existence. And indeed we therefore 
fully agree with the authors that we must talk about this dirty 
and well-kept secret that adversely affects the health of the 
vast majority of the population worldwide.2 In fact, 80% of the 
global population lives in low and middle-income countries 
(LMICs) that are severely impacted by corruption. Within 
these countries, most people are from poor socio-economic 
backgrounds and disproportionately suffer from the problem 
of corruption in their health systems.2
Even the most prestigious medical scientific journals claim 
that they want to advance the science and art of medicine 
to ameliorate the public health by fostering a responsible 
and balanced discourse on significant issues that impact 
medicine, health care and health policy. So why are these 
medical scientific journals, that should guide policy-makers, 
managers, and clinicians, so reluctant to discuss the most 
important problem that hinders good medical care and public 
health in numerous countries worldwide?1-3 The editorial 
identifies five reasons not to discuss corruption within health 
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systems.1 In this commentary, we would like to pay a closer 
look at these five excuses for doing nothing.
The first excuse is that it is difficult to define corruption.1 
However, a very clear and simple definition has been 
provided by Transparency International: “abuse of entrusted 
power for private gain.”3 This definition covers all aspects of 
corruption within societies, including the health care sector. 
Corruption intentionally subdues public well-being to private 
welfare. Conduct of corruptors is characterized by dualism as 
it derives from both their profession and their self-interest. 
Corruption predominantly damages the poor as they can 
neither pay bribes nor afford private alternatives.4-7
The second excuse for doing nothing is that some corrupt 
practices are actually ways of making dysfunctional systems 
work.1 This misconception has very serious and even deadly 
consequences. Corruption has a major effect on the structure 
of health systems.2 By denying that this dysfunctional structure 
actually causes the problem, it cannot be rooted out. This 
misconception and denial has led to numerous invain efforts 
to improve the access and quality of medical care for patients 
in LMICs focusing on financing direct needs, like drugs or 
medical devices.2,7 The structure in which health systems 
operate is commonly disregarded. However, this dysfunctional 
structure sustains corruption and obstructs quality health 
care entry for poor people.2,7 The following key components 
of health system structures affected by corruption have been 
identified: “(a) Absent or failing monitoring systems for 
health budgets, personnel, and supplies; (b) No reward for 
good performance; (c) No punishment for misconduct; (d) 
Salaries for healthcare providers in public hospitals not in 
line with their educational background, skills, and training; 
and (e) Physician dual practices, absenteeism, and informal 
payments.”2 Governments of countries in which corruption 
is rife need to be pressured to address these key components 
of dysfunctional health systems in order to make a change.2,3
The third reason not to discuss the problem of corruption 
in health systems concerns the serious challenge to 
investigate corruption.1 This is a crucial point. Indeed, the 
current and rightful trend in medicine is that it should be 
evidence-based. However, the intrinsic nature of corruption 
implies that it involves secrecy and is therefore very much 
hidden.2,4 Consequently, the problem of corruption cannot 
be investigated as rigorously as other fields in medicine. Its 
investigation therefore will always be surrounded by more 
uncertainties than ideally desired. Unfortunately, this very 
aspect has discouraged many editors from medical scientific 
journals, who have the important responsibility to guide 
policy-makers, managers, and clinicians, from publishing 
important insights regarding the problem of corruption in 
health systems. Multiple times this was the reason why editors 
of so-called high-ranking journals decided not to publish 
our studies on corruption and hospital detention practices 
despite praising external peer reviews.2 An editorial decision 
to not publish and share crucial knowledge on corruption 
due to lack of empirical evidence, denies the striking reality 
that corruption paralyzes the provision of good medical care 
and public health.1-3 Corruption in medicine kills patients.1,2 
If editors decide not to talk about corruption due to lack of 
evidence, they should realize that by doing nothing, they 
facilitate the triumph of corruption in health systems. If 
editors are silent, policy-makers, managers, and clinicians are 
not informed. Without information, they cannot make proper 
decisions and introduce policies that could tackle corruption 
and benefit the vast majority of the world population, being 
the poor in LMICs.2 Maybe it is therefore time to deal with the 
harsh reality and acknowledge that there are two categories 
of topics in medical science: those that can be fully evidence-
based investigated and those that cannot. The latter studies, 
despite its obvious limitations, need to be shared with the 
health policy community, managers, clinicians and the 
general public in order to raise awareness about the problem 
of corruption in health systems and implement strategies that 
can actually save lives.1,2 
The fourth excuse addresses concerns that focusing on 
corruption is a form of victim blaming that ignores larger 
issues.1 In this regard, two important questions need to be 
answered. First of all, who are the real victims? And secondly, 
what are the larger issues at stake? The answer to the first 
question is clear: the victims are predominantly the poor in 
LMICs whose access to proper medical care is denied because 
they cannot afford to pay bribes or private alternatives.2,3 But 
what are the larger issues? The authors refer to the unequal 
distribution of global resources.1 Focus on corruption does 
however not imply that this unequal distribution is ignored. 
It is in fact the opposite, focusing on the root causes of 
corruption acknowledges this large issue and may help to 
address it.2 Historically, high-income countries have profited 
from the rich natural resources in their former colonies, 
from its corrupt local leaders and from its poor subordinates. 
But also today government and business leaders from high-
income countries bribe local leadership to secure contracts 
and impinge state decrees.2,4,8-10 These government and 
business deals foremost benefit the high-income countries, 
but also enrich local leaders, contaminate the environment, 
and pauperize the population.2,4,8-10 Politicians in high-income 
countries are silent about the dismal role their companies play 
in encouraging corruption in LMICs. 2,4,8-10 And also the media 
in these high-income countries, including medical scientific 
journals, are unwilling to report the genuine magnitude of 
the problem of corruption in LMICs and how it is stimulated 
by high-income countries.2,4,8-10 Without realistic accounts, 
critical awareness and indispensable amendments for the 
poor population are precluded. 2,3
The fifth excuse to do nothing is closely linked to the 
third: there is no research or empirical evidence yet how to 
effectively tackle corruption.1 Although this might be true 
in many LMICs, the passage of legislation and establishment 
of agencies to enforce the laws in Europe, Canada, and the 
United States has successfully evolved in civil and criminal 
investigations and convictions of government leaders and 
healthcare policy-makers. Unfortunately the latter, even when 
the evidence is conclusive, still do not receive the punishment 
they deserve in LMICs troubled by widespread corruption. 
This can partially be explained by the collectivist orientation 
in most of these LMICs. Preservation of social harmony and 
the culture of respect to those who hold higher positions 
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in society, like government leaders, policy-makers and 
hospital managers, are given absolute priority and prevent 
that superiors can be criticised or hold accountable. When 
misconduct is not penalised, corruption in these settings 
cannot be tackled.2,4 This should however not stop editors, 
policy-makers, managers, and clinicians to acknowledge that 
the problem exists. Once the full extent and pervasiveness 
of the problem is acknowledged in medical science, policy-
makers, managers, and clinicians can set up studies to 
investigate the effectiveness of intervention strategies. We 
would like to repeat here that you cannot change, what you 
do not acknowledge.2,3 To illustrate this, we will share some 
of our own pediatric oncology outreach program experiences 
with you.2,11-15 The survival of childhood cancer may be as high 
as 80% in high-income countries and is frequently less than 
30% in LMICs. One of the most important, yet commonly 
unreported, root causes for this large gap in survival is the 
problem of corruption in health systems.2,11-15 A few examples 
of the effects of corruption on cancer care in LMICs2 are: (a) 
Inexperienced medical staff provide complex medical care 
without supervision because the experienced doctors, who 
receive full-time salaries to staff public hospitals, are working 
in their private practices; (b) Scarce drugs and medical devices 
are overpriced, substandard or counterfeit; (c) Medical 
equipment in public hospitals is intentionally disabled and 
repair overpriced and adjourned to wrongly refer patients 
to private health facilities; (d) Closed departments and 
facilities; (e) Long waiting lists; (f) Delayed diagnostics and 
late or interrupted cancer treatment; (g) The bad reputation 
of the public health sector stimulates the use of alternative 
treatment; (h) The postponed seeking of medical help leads 
to advanced and often no longer curable stages of disease at 
diagnosis.2,12-15 The ultimate outcome of corruption in health 
systems is unnecessary poor childhood cancer survial.2,11-15 
Yet, the public health community does not see the urgency 
to acknowledge and address this dirty and well-kept secret. 
Maybe because the editors of medical scientific journals and 
global policy-makers have not witnessed themselves how 
innocent children are detained inside hospitals and corpses 
of patients are dumped in anonymous graves over unpaid 
medical bills.2,12-15 Maybe because they did not set up studies 
themselves to get the painful truth out. 2,12-15 Maybe because 
they did not listen to the numerous accounts of the suffering 
families involved.2,11-15 Maybe for these reasons it is relatively 
easy for them to put these studies in the “too difficult” tray, 
as rightfully mentioned in the editorial of Hutchinson et al,1 
with the excuse that there is not enough hard evidence to 
meet their high scientific standards. Maybe it is therefore that 
they choose to do nothing. 
However, the vast majority of the world population does 
not need editors of medical scientific journals and global 
policy-makers who solely and rigorously focus on evidence-
based medicine and thereby choose to look away and do 
nothing. The poor in LMICs need good and courageous 
people with high moral and ethical principles who realize that 
it is important to first acknowledge the problem of corruption 
in health systems, despite the obvious uncertainties involved, 
before you can change it. The poor need good editors, good 
policy-makers, good managers, and good clinicians. So yes, 
we fully agree with the authors that we first need to talk about 
corruption. But above all, we need good people who are 
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